TITLE

Comparison of the metabolic parameters and androgen level of umbilical cord blood in newborns of mothers with polycystic ovary syndrome and controls

AUTHOR(S)
Mehrabian, F.; Khani, B.
PUB. DATE
June 2014
SOURCE
Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p5
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Introduction: This study aimed to assess the metabolic parameters and androgen concentration in the cord blood of newborns of mothers with polycystic ovary syndrome (PCOS) in comparison with controls. Materials and Methods: This cross-sectional study was conducted in 2010-2011 in Isfahan, Iran. Biochemical tests were conducted on 40 infants, born from singleton pregnancies in women with PCOS and an equal number of controls. Results: The mean weight gain during pregnancy was higher in women with PCOS than in controls (16.02±4.39 vs. 9.10±2.20 kg, respectively, p<0.0001). The mean birth weight was lower in newborns of mothers with PCOS than in controls (2905.25±415.59 vs. 3223.25±425.02 vs. grams, respectively, p=0.001). The mean testosterone was higher in cord blood of newborns of PCOS women than in controls (5.58±3.20 vs. 2.28±0.62 pg/ml, p<0.0001). Triglycerides and LDL-C were lower in cord blood of newborns, born from PCOS women than in controls (p=0.001). The birth weight of the newborns of PCOS mothers was negatively correlated to free testosterone of cord blood (R=-0.26, p=0.04). Conclusion: The metabolic aberration in PCOS might influence fetal birth weight and cord blood lipid profile. These disorders may be caused by an exposure to elevated testosterone level during fetal life. The offspring of PCOS women may be at higher risk for chronic diseases in later life. The clinical impact of our findings should be confirmed in future longitudinal studies.
ACCESSION #
96841486

 

Related Articles

  • MY SILENT BATTLE WITH PCOS. Mukena, Mercy // Sister Namibia;Oct-Dec2016, Vol. 28 Issue 4, p30 

    The article presents the author's views on having polycystic ovary syndrome, a common health problem caused by an imbalance of reproductive hormones. Topics include the conditions resulting from having irregular periods, dealing with depression, and explaining PCOS to a partner. It also cites...

  • Inhibin secretion in women with the polycystic ovary syndrome before and after treatment with progesterone. Dafopoulos, Konstantinos; Venetis, Christos; Messini, Christina I.; Pournaras, Spyros; Anifandis, George; Garas, Antonios; Messinis, Ioannis E. // Reproductive Biology & Endocrinology;2011, Vol. 9 Issue 1, p59 

    Objectives: It has been suggested that inhibin secretion is altered in women with the polycystic ovary syndrome (PCOS). However, the contribution of a preceding luteal phase has not been taken into account. The aim of the present study was to investigate whether progesterone in the context of a...

  • Sympathetic nerve activity in normal and cystic follicles from isolated bovine ovary: local effect of beta-adrenergic stimulation on steroid secretion. Paredes, Alfonso H.; Salvetti, Natalia R.; Diaz, Ariel E.; Dallard, Bibiana E.; Ortega, Hugo H.; Lara, Hernan E. // Reproductive Biology & Endocrinology;2011, Vol. 9 Issue 1, p66 

    Cystic ovarian disease (COD) is an important cause of abnormal estrous behavior and infertility in dairy cows. COD is mainly observed in high-yielding dairy cows during the first months post-partum, a period of high stress. We have previously reported that, in lower mammals, stress induces a...

  • Evaluation of Ovarian Cysts. HOLZER, ROBIN A.; PERSONS, ROBERT K.; JAMIESON, BARBARA // American Family Physician;8/1/2011, Vol. 84 Issue 3, p3 

    The article provides an answer to a question of what type of follow-up should a physician conduct for a patient with an ovarian cyst identified on ultrasonography.

  • Is Pentraxin 3 a New Cardiovascular Risk Marker in Polycystic Ovary Syndrome? Sari, Umut; Kaygusuz, Ikbal; Kafali, Hasan // Gynecologic & Obstetric Investigation;Sep2014, Vol. 78 Issue 3, p173 

    Background/Aims: Polycystic ovary syndrome (PCOS) patients have an increased rate of subclinical inflammation, which plays a role in the pathogenesis of atherosclerosis. Pentraxin 3 (PTX3) is an inflammatory mediator which belongs to the same family as the well-established cardiovascular...

  • Lateralization of Ovarian Follicles. AlSerri, Abdulrahman; Kuriya, Anita; Holzer, Hananel; Tulandi, Togas // Gynecologic & Obstetric Investigation;Feb2014, Vol. 77 Issue 2, p117 

    Background/Aim: To evaluate a possible lateralization of antral follicle count (AFC) based on the finding that endometriosis, if present, is more commonly found in the left hemipelvis. Methods: We evaluated the records of 6,617 baseline ultrasounds conducted at our Reproductive Center between...

  • ZABURZENIA PSYCHOSEKSULNE U KOBIET Z ZESPOŁEM POLICYSTYCZNYCH JAJNIKÓW. Specjalski, Radosław // Polish Nursing / Pielegniarstwo Polskie;2013, Vol. 49 Issue 3, p230 

    Polycystic ovary syndrome (PCOS) is the most common endocrinological disorder in women of reproductive age. The main clinical features of PCOS include abnormal ovulation, clinical or laboratory indices of elevated androgen levels and polycystic morphology of the ovaries. The spectrum of its...

  • THE 411 ON PCOS.  // Shape;Sep2011, Vol. 31 Issue 1, p103 

    The article offers information about polycystic ovary syndrome (PCOS) including its prevalence among women, symptoms such as acne and irregular menstruation, and treatment with birth control pills.

  • Placental characteristics in women with polycystic ovary syndrome. Koster, Maria P. H.; de Wilde, Marlieke A.; Veltman-Verhulst, Susanne M.; Houben, Michiel L.; Nikkels, Peter G. J.; van Rijn, Bas B.; Fauser, Bart C. J. M. // Human Reproduction;Dec2015, Vol. 30 Issue 12, p2829 

    Study Question: Are macroscopic and microscopic placental characteristics in a heterogeneous group of women diagnosed with polycystic ovary syndrome (PCOS) different from those of a low-risk general population?Summary Answer: Women with PCOS have significantly different...

  • AQP8 and AQP9 expression in patients with polycystic ovary syndrome and its association with in vitro fertilization-embryo transfer outcomes. Xiong, Zhengfang; Li, Bing; Wang, Liyun; Zeng, Xianghui; Li, Binye; Sha, Xiaoyan; Liu, Huishu // Experimental & Therapeutic Medicine;Jul2019, Vol. 18 Issue 1, p755 

    The aim of the present study was to investigate aquaporin (AQP)8 and AQP9 expression in patients with polycystic ovary syndrome (PCOS) and its association with in vitro fertilization-embryo transfer (IVF-ET) outcomes. A total of 45 patients with PCOS undergoing IVF-ET (test group) and 50...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics